Interleukin-5 inhibition of biliary cell chloride currents and bile flow

James M. McGill, Margaret S. Yen, Oscar Cummings, Gianfranco Alpini, Gene Lesage, Karen Pollok, Barbara Miller, Steven K. Engle, Ann P. Stansfield

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Recent studies have detected significant elevations of interleukin (IL)-5 mRNA in the liver parenchyma of patients with both primary biliary cirrhosis and acute rejection after liver transplantation. In both of these disorders, intrahepatic biliary epithelial cells (BECs) are the targets of injury. We hypothesized that BECs may themselves express IL-5 receptors that may modulate key biliary functions. RNAs coding for IL-5α and -β receptors were amplified by RT/PCR from a biliary cell line derived from a human cholangiocarcinoma (Mz-ChA-1) and verified by DNA sequencing. IL-5 receptor distribution was detected immunocytochemically on Mz-ChA-1 cells, immortalized murine BEC, bile duct-ligated rat liver, and isolated cholangiocytes. Patch-clamp studies on Mz-ChA-1 cells showed that IL-5 inhibits 5′-N-ethylcarboxamidoadenosine-stimulated chloride currents. Additional functional studies showed that IL-5 inhibits secretin-induced bile flow. We conclude that BECs express IL-5 receptors and that IL-5 modulates BEC chloride currents and fluid secretion. Since IL-5 has previously been associated with cholestatic liver disease, we speculate that IL-5 may contribute to liver injury through its effects on biliary secretion.

Original languageEnglish
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Volume280
Issue number4 43-4
StatePublished - Apr 2001

Fingerprint

Interleukin-5
Interleukin-5 Receptors
Bile
Chlorides
Epithelial Cells
Liver
Adenosine-5'-(N-ethylcarboxamide)
Fluids and Secretions
Secretin
Cholangiocarcinoma
Biliary Liver Cirrhosis
Wounds and Injuries
Bile Ducts
DNA Sequence Analysis
Liver Transplantation
Liver Diseases
RNA
Cell Line
Polymerase Chain Reaction
Messenger RNA

Keywords

  • Chloride channel
  • Cholestatic liver disease
  • Patch-clamp recording

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology
  • Physiology (medical)

Cite this

Interleukin-5 inhibition of biliary cell chloride currents and bile flow. / McGill, James M.; Yen, Margaret S.; Cummings, Oscar; Alpini, Gianfranco; Lesage, Gene; Pollok, Karen; Miller, Barbara; Engle, Steven K.; Stansfield, Ann P.

In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 280, No. 4 43-4, 04.2001.

Research output: Contribution to journalArticle

McGill, JM, Yen, MS, Cummings, O, Alpini, G, Lesage, G, Pollok, K, Miller, B, Engle, SK & Stansfield, AP 2001, 'Interleukin-5 inhibition of biliary cell chloride currents and bile flow', American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 280, no. 4 43-4.
McGill, James M. ; Yen, Margaret S. ; Cummings, Oscar ; Alpini, Gianfranco ; Lesage, Gene ; Pollok, Karen ; Miller, Barbara ; Engle, Steven K. ; Stansfield, Ann P. / Interleukin-5 inhibition of biliary cell chloride currents and bile flow. In: American Journal of Physiology - Gastrointestinal and Liver Physiology. 2001 ; Vol. 280, No. 4 43-4.
@article{0d943a790f1f4b05bbf332e06040a5f4,
title = "Interleukin-5 inhibition of biliary cell chloride currents and bile flow",
abstract = "Recent studies have detected significant elevations of interleukin (IL)-5 mRNA in the liver parenchyma of patients with both primary biliary cirrhosis and acute rejection after liver transplantation. In both of these disorders, intrahepatic biliary epithelial cells (BECs) are the targets of injury. We hypothesized that BECs may themselves express IL-5 receptors that may modulate key biliary functions. RNAs coding for IL-5α and -β receptors were amplified by RT/PCR from a biliary cell line derived from a human cholangiocarcinoma (Mz-ChA-1) and verified by DNA sequencing. IL-5 receptor distribution was detected immunocytochemically on Mz-ChA-1 cells, immortalized murine BEC, bile duct-ligated rat liver, and isolated cholangiocytes. Patch-clamp studies on Mz-ChA-1 cells showed that IL-5 inhibits 5′-N-ethylcarboxamidoadenosine-stimulated chloride currents. Additional functional studies showed that IL-5 inhibits secretin-induced bile flow. We conclude that BECs express IL-5 receptors and that IL-5 modulates BEC chloride currents and fluid secretion. Since IL-5 has previously been associated with cholestatic liver disease, we speculate that IL-5 may contribute to liver injury through its effects on biliary secretion.",
keywords = "Chloride channel, Cholestatic liver disease, Patch-clamp recording",
author = "McGill, {James M.} and Yen, {Margaret S.} and Oscar Cummings and Gianfranco Alpini and Gene Lesage and Karen Pollok and Barbara Miller and Engle, {Steven K.} and Stansfield, {Ann P.}",
year = "2001",
month = "4",
language = "English",
volume = "280",
journal = "American Journal of Physiology",
issn = "0193-1857",
publisher = "American Physiological Society",
number = "4 43-4",

}

TY - JOUR

T1 - Interleukin-5 inhibition of biliary cell chloride currents and bile flow

AU - McGill, James M.

AU - Yen, Margaret S.

AU - Cummings, Oscar

AU - Alpini, Gianfranco

AU - Lesage, Gene

AU - Pollok, Karen

AU - Miller, Barbara

AU - Engle, Steven K.

AU - Stansfield, Ann P.

PY - 2001/4

Y1 - 2001/4

N2 - Recent studies have detected significant elevations of interleukin (IL)-5 mRNA in the liver parenchyma of patients with both primary biliary cirrhosis and acute rejection after liver transplantation. In both of these disorders, intrahepatic biliary epithelial cells (BECs) are the targets of injury. We hypothesized that BECs may themselves express IL-5 receptors that may modulate key biliary functions. RNAs coding for IL-5α and -β receptors were amplified by RT/PCR from a biliary cell line derived from a human cholangiocarcinoma (Mz-ChA-1) and verified by DNA sequencing. IL-5 receptor distribution was detected immunocytochemically on Mz-ChA-1 cells, immortalized murine BEC, bile duct-ligated rat liver, and isolated cholangiocytes. Patch-clamp studies on Mz-ChA-1 cells showed that IL-5 inhibits 5′-N-ethylcarboxamidoadenosine-stimulated chloride currents. Additional functional studies showed that IL-5 inhibits secretin-induced bile flow. We conclude that BECs express IL-5 receptors and that IL-5 modulates BEC chloride currents and fluid secretion. Since IL-5 has previously been associated with cholestatic liver disease, we speculate that IL-5 may contribute to liver injury through its effects on biliary secretion.

AB - Recent studies have detected significant elevations of interleukin (IL)-5 mRNA in the liver parenchyma of patients with both primary biliary cirrhosis and acute rejection after liver transplantation. In both of these disorders, intrahepatic biliary epithelial cells (BECs) are the targets of injury. We hypothesized that BECs may themselves express IL-5 receptors that may modulate key biliary functions. RNAs coding for IL-5α and -β receptors were amplified by RT/PCR from a biliary cell line derived from a human cholangiocarcinoma (Mz-ChA-1) and verified by DNA sequencing. IL-5 receptor distribution was detected immunocytochemically on Mz-ChA-1 cells, immortalized murine BEC, bile duct-ligated rat liver, and isolated cholangiocytes. Patch-clamp studies on Mz-ChA-1 cells showed that IL-5 inhibits 5′-N-ethylcarboxamidoadenosine-stimulated chloride currents. Additional functional studies showed that IL-5 inhibits secretin-induced bile flow. We conclude that BECs express IL-5 receptors and that IL-5 modulates BEC chloride currents and fluid secretion. Since IL-5 has previously been associated with cholestatic liver disease, we speculate that IL-5 may contribute to liver injury through its effects on biliary secretion.

KW - Chloride channel

KW - Cholestatic liver disease

KW - Patch-clamp recording

UR - http://www.scopus.com/inward/record.url?scp=0035012065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035012065&partnerID=8YFLogxK

M3 - Article

C2 - 11254501

AN - SCOPUS:0035012065

VL - 280

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1857

IS - 4 43-4

ER -